Fervex dry cough

Quick links

Choose a section

Quick links to important sections

Advertisements

Fervex dry cough

Selected form

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Fervex dry cough

Property Description
Active Ingredient Acetaminophen, Dextromethorphan HBr, Ascorbic Acid
Form Powder for Oral Solution (Sachet)
Pharmacological Class Analgesic, Antipyretic, and Antitussive Agent
Common Use Symptomatic relief of dry cough, pain, and fever
Origin Primarily Synthetic (Multicomponent)

Fervex Dry Cough is defined as a dedicated, Over-The-Counter (OTC) preparation intended for oral administration as a Fixed-Dose Combination (FDC) agent. This product is classified as a triple-action medicine, serving as an Analgesic, an Antipyretic, and an Antitussive. Its unique delivery method, a powder for oral solution packaged in individual sachets, allows for quick preparation as a warm drink, differentiating it from traditional tablet forms.

The product's composition consists of three distinct active ingredients: Acetaminophen, Dextromethorphan Hydrobromide, and Ascorbic Acid. Acetaminophen is used for the reduction of fever and general body aches. The preparation's specificity toward dry cough is established by Dextromethorphan Hydrobromide, a synthetically derived agent that is a widely adopted antitussive. Dextromethorphan acts to suppress the cough reflex by decreasing the relevant activity in the central nervous system. Ascorbic Acid is incorporated as a supplemental component, a common feature in cold formulations.

The primary purpose of Fervex Dry Cough is to provide integrated symptomatic relief during non-productive coughing illnesses. It targets the physical burdens often experienced simultaneously: the pain and fever associated with infection and the irritation caused by a persistent dry cough. This combination makes the product suitable for users seeking a single solution to mitigate these three concurrent symptoms.

Regulatory References

  1. Dextromethorphan: Mechanism of Action and CNS Effects (NIH/NCBI)
Advertisements

What side effects are possible with Fervex dry cough?

Possible Side Effects and Safety Information

This section describes the adverse reactions and high-level safety constraints documented in official regulatory sources for medicines containing Acetaminophen, Dextromethorphan Hydrobromide, and Ascorbic Acid.


Frequency and System-Organ Classification

Adverse reactions are classified by frequency and the physiological system affected, as presented in regulatory documentation. Common effects, reported in official labeling, primarily involve the Nervous System Disorders and Gastrointestinal Disorders, including dizziness and somnolence (drowsiness) associated with the antitussive component, and minor nausea or vomiting.

Rare and Very Rare effects involve the Immune System, Skin and Subcutaneous Tissue, and the Blood and Lymphatic System. These may include hypersensitivity reactions, rash, and the documented possibility of blood dyscrasias like agranulocytosis.


Serious Adverse Reactions and Safety Constraints

The most serious documented safety concerns are explicitly highlighted in regulatory texts:

  • Hepatotoxicity: The potential for severe hepatic injury and hepatic failure is a major documented risk associated with the Acetaminophen content. The product is therefore contraindicated in severe hepatocellular insufficiency.
  • Serotonin Syndrome: The cough suppressant, Dextromethorphan, carries a documented risk for Serotonin Syndrome when used in combination with certain other medications. This combination is contraindicated for use in individuals who have taken a Monoamine Oxidase Inhibitor (MAOI) within the prior two weeks.
  • Severe Cutaneous Adverse Reactions (SCARs): Very rare but serious skin reactions, including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are documented risks related to the analgesic component.

Older adults may have an increased susceptibility to the central nervous system effects, such as dizziness.

Advertisements

Overdose and Emergency Response

Any suspected overdose with this combination product requires immediate medical attention. Government regulatory documentation mandates that emergency services or a poison control center be contacted right away, even if no severe symptoms are apparent. This is due to the potential for severe, life-threatening complications that may be delayed in onset.

The most severe risk stems from the Acetaminophen component, which can lead to progressive, irreversible severe liver damage (hepatotoxicity) and acute liver failure. Initial symptoms may include nausea, vomiting, and diaphoresis. The efficacy of the specific antidote, N-acetylcysteine (NAC), is time-sensitive, defining the urgency of the required medical intervention. Individuals with a history of chronic alcohol use or pre-existing liver disease are documented to have an increased vulnerability to this severe injury.

Toxicity from the Dextromethorphan component presents with acute Central Nervous System (CNS) effects. These include documented manifestations such as agitation, hallucinations, loss of coordination (ataxia), and, in severe cases, seizures, respiratory depression, or the potential development of Serotonin Syndrome. Management involves supportive care, continuous hospital monitoring, and specialized medical procedures like the time-sensitive administration of activated charcoal, as described in official protocols.

Advertisements

Therapeutic Uses of Fervex dry cough

What Fervex Dry Cough Treats: Main Uses and Benefits


The primary therapeutic role of this fixed-dose combination product is to offer integrated, supportive relief for the collection of symptoms typically experienced during acute, non-productive coughing illnesses like the common cold or flu. It is commonly used when short-term symptomatic assistance is needed in the adult population. The combination of a cough suppressant and a pain/fever reducer is recognized for managing the distressing symptoms that often cluster together.

Integrated Symptomatic Relief

This preparation is generally applied across areas where additional symptomatic support is needed, such as in conditions characterized by periods of heightened symptoms like viral rhinitis or flu-like syndromes. It is commonly used for managing symptom clusters that may become intense or disruptive, including dry cough, minor body aches, headache, and elevated temperature. The product provides support that contributes to easing the overall symptom burden of these concurrent manifestations.

“It is applied in clinical settings that involve acute or unstable symptom patterns, contributing to improved comfort during symptomatic periods.”

Targeted Relief Domains

The medication is applied in addressing symptoms that become more disruptive, especially when they interfere with rest. Symptomatic support may assist with temporary reduction in the urge to cough, which contributes to improved comfort during periods of heightened symptoms. It further supports the patient during difficult episodes, which may assist with maintaining a sense of stability and assists with maintaining functional stability when symptoms are more noticeable.


Quick Fact: Relief for Concurrent Symptom Burden
Is commonly used for managing the simultaneous manifestation of a dry cough, fever, and minor pain during acute viral illnesses.

Regulatory References

  1. NIH MedlinePlus overview of Dextromethorphan
Advertisements

Eligibility and Restrictions for Use

Fervex dry cough is typically formulated with Dextromethorphan (DM), or in some regions, as a multi-ingredient product with DM, Paracetamol, and Pheniramine. Eligibility is strictly defined by regulatory label warnings.

Populations for Whom Use Is Contraindicated

Classification Regulatory Statement (Must Not Use)
Age Children under 12 years of age (DM-only) or 15 years of age (multi-ingredient Fervex).
Co-Medication Patients taking a Monoamine Oxidase Inhibitor (MAOI) or who have taken one within the preceding 14 days.
Co-Medication Patients taking a prescription SSRI or other medications for depression, psychiatric, or emotional conditions.
Conditions Individuals with known hypersensitivity to the ingredients.
Conditions Patients with, or at risk of developing, respiratory failure (e.g., severe asthma or pneumonia).
Conditions Certain forms of glaucoma or risk of urinary retention (for multi-ingredient products).
Conditions Severe liver disease or certain rare hereditary metabolic disorders (e.g., fructose intolerance).

Eligibility-Related Restrictions

  • Pregnancy and Lactation: Use is not recommended or contraindicated. Official sources advise against use during pregnancy and breastfeeding unless considered essential by a physician, as safety is not fully established.
  • Organ Function: Caution should be exercised in the presence of hepatic (liver) impairment. Medical advice should be sought before use in patients with severe renal (kidney) impairment.
  • Chronic Cough: The product should only be used by patients with chronic or persistent cough (e.g., associated with asthma or emphysema) under the direction of a physician.

These restrictions define the officially eligible population as generally being Adults and adolescents (over 12 or 15 years, depending on the specific product) who do not have any listed contraindicating medications or medical conditions.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Fervex dry cough (containing Dextromethorphan and potentially other active ingredients like Paracetamol and Pheniramine) requires careful management of concomitant medications.

Contraindicated and High-Risk Combinations

Monoamine Oxidase Inhibitors (MAOIs) are strictly contraindicated. Co-administration with MAOIs, or within 14 days of stopping them, carries a high risk of developing a severe serotonin syndrome due to enhanced serotonergic activity.

Pharmacodynamic Interactions

Alcohol and other CNS depressants (including sedative medicines) should be avoided. These substances can potentiate the risk of drowsiness and reduced vigilance, which can impair the ability to drive or operate machinery. The product must not be combined with alcoholic beverages or alcohol-containing medicines.

Pharmacokinetic and Dose Duplication Constraints

Caution is required with medicines that are potent CYP2D6 inhibitors (e.g., Quinidine), as they can increase the concentration of Dextromethorphan, raising the risk of adverse effects. Furthermore, patients must not combine this product with other medicines that contain Paracetamol (Acetaminophen) or Antihistamines to prevent inadvertently exceeding the maximum daily dose and risking overdose.

Advertisements

Mechanism of Action

How Fervex Dry Cough Works


The action of this fixed-dose combination targets distinct central pathways to modulate physiological responses associated with systemic illness. Its action is mediated by three separate, complementary mechanisms.

Central Suppression of the Medullary Cough Reflex

The antitussive mechanism is achieved by an ingredient that acts within the brainstem cough center, primarily through agonism of the Sigma-1 receptor (sigma1) and antagonism of the NMDA receptor. This central modulation decreases the excitability of the cough reflex arc, resulting in an elevation of the cough threshold.


Modulation of Hypothalamic Thermoregulation and Nociception

Antipyretic and analgesic actions are driven by the inhibition of the Cyclooxygenase ( COX) enzyme system, selectively in the central nervous system. This results in reduced PGE2 synthesis in the hypothalamus, which leads to the restoration of the body's thermoregulatory set-point and reduces the central transmission of nociceptive signals.


Supplementary Redox and Immune Support

A third ingredient contributes a systemic, non-symptomatic action by functioning as an antioxidant and cofactor in cellular processes. This mechanism contributes to cellular redox maintenance and is involved in the modulation of immune cell function.

Advertisements

Dosage and Administration Information

How to Use Fervex Dry Cough

The usage of this fixed-dose combination product follows standardized protocols defining the appropriate route, preparation, and limits for administration.

Approved Route and Preparation

The approved route of administration for this medicine is oral use, consistent with its form as a powder for oral solution. For proper administration, established instructions require specific preparation:

  • The entire contents of one packet must be dissolved completely in a glass of water, which may be hot or cold.
  • The resulting solution is then consumed orally. In cases of flu-like states, taking the solution while warm may be recommended.

Standard Dosing and Administration Schedule

Standardized dosing is based on the Paracetamol (Acetaminophen) component, mandating adherence to precise limits and intervals.

Population Single Dose Administration Frequency Maximum Daily Dose
Adults and Children 12 years and over One packet Every 4 hours (minimum interval) Do not exceed 4 packets in 24 hours (based on a 1000 mg dose)

Note: Dosing recommendations may vary by country; the regimen above reflects common standards for this combination.

Duration of Use and Special Conditions

Treatment with this over-the-counter medicine is restricted to a short duration. The total course of treatment should not exceed 5 to 7 days. If symptoms of pain or fever persist beyond 3 days, or if the cough does not improve within 5 days, administration should be stopped. Use is limited to the population 12 years of age and over.

Advertisements

Recent Clinical Evidence

Fervex Dry Cough: Recent Clinical Evidence

Clinical evidence for products targeting dry cough focuses on the active ingredient intended to suppress the cough reflex, typically an antitussive such as Dextromethorphan (DM). The mechanism of action for this class of medication is generally understood to involve regulating the cough center in the brain, which may reduce the urge to cough.


Efficacy in Acute Dry Cough

Studies evaluating antitussives for acute, non-specific cough in adults have yielded mixed results. Randomized controlled trials (RCTs) often compare the effect of Dextromethorphan to that of a placebo. While some research has observed a difference in cough frequency or severity, other systematic reviews have reported limited or conflicting evidence to demonstrate a significant clinical benefit over placebo for the temporary relief of acute dry cough.

Area of Study Key Research Finding (Observed)
Cough Frequency Some trials reported a statistically significant reduction in cough count for the treatment group.
Cough Severity Findings from multiple reviews suggest that the overall effect size may be small and its clinical relevance is uncertain.

Safety and Tolerability Profile

Safety studies have monitored the tolerability of antitussive ingredients like Dextromethorphan in adults. When used according to label instructions, the drug is generally associated with a low incidence of serious adverse events. The most frequently reported mild side effects in clinical trials include:

  • Dizziness or lightheadedness
  • Drowsiness (somnolence)
  • Gastrointestinal upset (e.g., nausea)

These data reflect the outcomes observed during controlled studies and are used by regulatory bodies to assess the risk-benefit profile of the treatment.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Fervex dry cough (FAQ)

Q: How quickly should I expect Fervex dry cough to start working?

The antitussive ingredient in the product (Dextromethorphan) is typically absorbed quickly after taking it. Regulatory information indicates that the duration of effect for a single dose is approximately three to eight hours. This range suggests when symptom relief may begin for many users.

Q: Is it normal to feel a bit dizzy after taking Fervex dry cough?

Yes, regulatory documents list dizziness and somnolence (drowsiness) as common side effects associated with the cough-suppressant component of the medicine. Since these effects are common, feeling dizzy is a documented and expected possibility for some people using the product.

Q: Can children take Fervex dry cough?

The product is generally contraindicated for use in children under the age of 12 years, or under 15 years, depending on the specific combination product's formulation. Regulatory warnings state that use in children below the eligible age requires consultation with a healthcare professional.

Q: Is Fervex dry cough safe for use during pregnancy?

Official sources advise against the use of this product during pregnancy and breastfeeding. Safety has not been fully established. Regulatory documents state that use during pregnancy is advised against, and a healthcare professional should be consulted if treatment is considered necessary.

Q: Why does Fervex dry cough sometimes cause an upset stomach?

Minor gastrointestinal discomfort, which may include nausea and vomiting, is listed as a common adverse reaction for the active ingredients in regulatory information. If persistent or severe stomach upset is experienced, the product's official warnings should be reviewed.

Q: Is it okay to take Fervex dry cough if I'm taking allergy medication?

Caution is required. Regulatory warnings advise against combining this product with other medicines that contain Antihistamines. This warning is in place to prevent the risk of exceeding safe doses and to mitigate increased risk of side effects like drowsiness.

Q: Does Fervex dry cough suppress the cough reflex completely?

The medicine works by affecting the brain's cough center, which elevates the cough threshold. This action reduces the urge to cough and suppresses the reflex. However, the product is intended for temporary, symptomatic relief and may not eliminate the cough reflex entirely.

Q: Why might a doctor or pharmacist recommend Fervex dry cough?

The product is indicated for the integrated, symptomatic relief of three concurrent issues: dry cough, pain, and fever. Healthcare professionals may recommend it when a patient presents with this specific combination of symptoms during a non-productive coughing illness.

Q: Does Fervex dry cough help with post-nasal drip that causes a dry cough?

As an antitussive, this product is designed to suppress the cough reflex itself. It does not treat the underlying cause of the cough, such as post-nasal drip. Because it does not treat the cause, the cough may not be fully resolved if the post-nasal drip persists.

Q: Is Fervex dry cough meant for an acute or chronic dry cough?

Official product information indicates that this medicine is for the temporary, symptomatic relief of cough. Regulatory warnings advise that chronic (long-term) or persistent cough, such as one associated with asthma, requires the guidance of a healthcare professional.

Q: What happens if I take Fervex dry cough close to my bedtime?

The cough-suppressant ingredient is associated with drowsiness (somnolence) as a common side effect. Because of this effect, taking the product close to bedtime may promote drowsiness or aid with sleep disturbances caused by the cough.

Q: Can people with diabetes use Fervex dry cough?

Some multi-ingredient cold and flu products are contraindicated or require special caution in patients with diabetes mellitus. Individuals with diabetes are advised to check the product’s full list of excipients, particularly for sugar content, and consult with a healthcare professional before use.

Q: Does Fervex dry cough contain sugar or sweeteners?

The powder for oral solution form of combination cold/flu products frequently contains excipients such as Sucrose or other sweeteners to improve taste. The specific list of excipients should be confirmed by reviewing the product label or regulatory leaflet.

Q: What if my dry cough doesn't improve after taking Fervex dry cough for a few days?

Official warnings state that treatment should not exceed five to seven days. If the cough persists, worsens, or is accompanied by new symptoms after five days of use, official warnings advise that the medicine should be discontinued, and a healthcare professional should be consulted.

Q: Can Fervex dry cough cause insomnia or difficulty sleeping?

While the product can cause drowsiness, some combination cold/flu products may also list side effects such as sleep problems, nervousness, or restlessness. If difficulty sleeping is experienced, consulting the label for specific warnings is advised.

Q: Are there generic versions of the active ingredients in Fervex dry cough?

Yes, the main active ingredients—Acetaminophen, Dextromethorphan, and Ascorbic Acid—are widely known and are commonly available individually as generic, non-branded medications in the market.

Q: Can Fervex dry cough interact with herbal supplements?

Official regulatory warnings advise that consultation with a healthcare professional is necessary before use if taking any herbal or other dietary supplements. This is due to the potential for interactions between the substances.

Q: Is Fervex dry cough safe for older adults or the elderly?

The standard adult dose is often applicable to older adults. However, older individuals may have an increased susceptibility to central nervous system effects, such as dizziness and drowsiness, and official warnings state that caution should be exercised in this population.

Q: Is Fervex dry cough available in liquid form or only as a powder?

The specific preparation being discussed is officially defined as a 'powder for oral solution' packaged in individual sachets. The final solution is prepared by dissolving the powder in water.

Q: Can Fervex dry cough cause allergic reactions?

Yes, allergic responses, rash (hypersensitivity reactions), and in very rare cases, severe cutaneous adverse reactions (SCARs) are documented risks associated with the ingredients. Any signs of an allergic reaction are considered grounds for discontinuing use and seeking immediate professional medical assessment.

Q: Are there any warnings about combining Fervex dry cough with blood thinners?

Caution is advised when using this product if a patient is already taking a blood thinning drug (anticoagulant), such as warfarin. Regulatory documents require consultation with a healthcare professional before combining these medications.

Q: Does Fervex dry cough contain any ingredients for pain relief or fever?

Yes, the formulation contains Acetaminophen (Paracetamol), which is indicated for its analgesic (pain relief) and antipyretic (fever reducing) properties. This confirms its role as a triple-action product for cough, pain, and fever.

Q: Why is Fervex dry cough sometimes recommended for nighttime dry cough?

Because the product contains an ingredient that is associated with causing drowsiness (somnolence), some formulations may be recommended for relief of persistent dry cough symptoms at night to help promote rest.

Q: Does Fervex dry cough help with a scratchy throat?

Yes, the product is indicated for the symptomatic relief of pain. This means it can help mitigate pain or irritation, which includes the discomfort associated with a scratchy throat.

Advertisements

How should Fervex dry cough be stored and disposed of?

Storage Requirements

Fervex Dry Cough (powder for oral solution) must be stored under specific environmental constraints to maintain stability, as dictated by regulatory bodies.

Storage Parameter Regulatory Requirement
Temperature Store at a temperature not exceeding 25^circC (or controlled room temperature, 15^circC to 30^circC).
Protection Keep the powder in the original container and protect it from excessive heat and moisture. Do not store in high-humidity areas, such as a bathroom.
Child Safety The medicine must be kept out of the sight and reach of children.

Disposal Instructions

Medicines must be discarded safely to protect the environment and prevent accidental exposure.

  • Wastewater Prohibition: Do not dispose of the unused medicine by pouring it down a sink or toilet, as the product is not on the list of medications recommended for flushing.
  • Recommended Method: The preferred way to discard expired or unused sachets is by using a formal drug take-back program or medicine disposal site in your community.
  • Household Disposal: If no take-back program is available, the product may be mixed with an undesirable substance (e.g., used coffee grounds), sealed in a plastic bag, and placed in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fervex dry cough found in:

A-Z Index: